nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.21682/2311-1267-2020-7-4-77-81nodgo-671Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSРоль магнитно-резонансной томографии в диагностике злокачественных новообразований костей. Современное состояние вопросаThe role of magnetic resonance imaging in the diagnosis of malignant bone neoplasms. Current state of an issuehttps://orcid.org/0000-0001-8888-2797ВалеевА. И.ValeevA. I.

Валеев Алмаз Ильдарович - врач-рентгенолог кафедры онкологии с курсом лучевой диагностики и лучевой терапии КазГМУ Минздрава России.420012, Республика Татарстан, Казань, ул. Бутлерова, 49.SPIN-код: 8150-7841

Radiologist of the Department of Oncology with a course of Radiation Diagnostics and Radiation Therapy of Kazan State Medical University of the Ministry of Health of Russia.49 Butlerova St., Kazan, Republic of Tatarstan, 420012.SPIN-code: 8150-7841

valealmaz@yandex.ruhttps://orcid.org/0000-0003-3261-9986МаловА. А.MalovA. A.

Ассистент кафедры онкологии с курсом лучевой диагностики и лучевой терапии КазГМУ Минздрава России.420012, Республика Татарстан, Казань, ул. Бутлерова, 49.SPIN-код: 3807-6209

Assistant of the Department of Oncology with a course of Radiation Diagnostics and Radiation Therapy of Kazan State Medical University of the Ministry of Health of Russia.49 Butlerova St., Kazan, Republic of Tatarstan, 420012.SPIN-code: 3807-6209

malov_aleksei@inbox.ruКазанский государственный медицинский университет Минздрава РоссииРоссияKazan State Medical UniversityRussian Federation202007012021747781Copyright © Валеев А.И., Малов А.А., 20212021Валеев А.И., Малов А.А.Valeev A.I., Malov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/671

В обзорной статье освещаются вопросы клинического опыта применения современных томографических методов (магнитно-резонансной томографии (МРТ) и рентгеновской компьютерной томографии (КТ)) в диагностике и оценке прогрессирования злокачественных новообразований костей, резюмируются результаты наиболее крупных исследований, демонстрирующих сравнительную характеристику методов. Многочисленные данные демонстрируют высокую чувствительность МРТ и формируют следующие диагностические задачи, решаемые данным методом: степень вовлечения в патологический процесс мягких тканей, поражение нервно-сосудистого пучка, суставной поверхности, оценка протяженности опухоли в костномозговом канале. В то же время КТ демонстрирует более высокую чувствительность в оценке кортикальной деструкции и степени минерализации матрикса. В статье рассматриваются разнообразие программных последовательностей и режимов МР-сканирования, перспективы метода в оценке распространенности, стадирования и дифференциальной диагностики опухолей костей.

The review article is about clinical experience in the use of modern tomographic methods (magnetic resonance imaging (MRI) and X-ray computed tomography (CT)) in the diagnosis and assessment of the progression of malignant bone neoplasms, summarizing the results of the largest studies demonstrating the comparative characteristics of the methods. Numerous data demonstrate high sensitivity of MRI and form the following diagnostic tasks that can be solved by this method: the involvement degree of soft tissues in the pathological process, damage to the neurovascular bundle, the articular surface, assessment of the extent of tumor in the bone marrow canal. At the same time, CT shows a higher sensitivity in assessing cortical destruction and the degree of matrix mineralization. The article discusses the variety of program sequences and modes of MRI scanning, the prospects of the method in assessing the prevalence, staging, and differential diagnosis of bone tumors.

опухоли костейсаркомымагнитно-резонансная томографиякомпьютерная томографияbone tumorssarcomasmagnetic resonance imagingcomputed tomographyReferencesKransdorf M.J., Bridges M.D. Current developments and recent advances in musculoskeletal tumor imaging. Semin Musculoskelet Radiol 2013;17(2):145-55. doi: 10.1055/s-0033-1343070.Kransdorf M.J., Bridges M.D. Current developments and recent advances in musculoskeletal tumor imaging. Semin Musculoskelet Radiol 2013;17(2):145-55. doi: 10.1055/s-0033-1343070.Dorfman H.D., Czerniak B., Kotz R., Vanel D., Park Y.K., Unni K.K. WHO classification of tumours of bone: introduction. In: Fletcher C.D.M., Unni K.K., Mertens F., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Geneva: IARC Press; 2002. Pp. 227-232.Dorfman H.D., Czerniak B., Kotz R., Vanel D., Park Y.K., Unni K.K. WHO classification of tumours of bone: introduction. In: Fletcher C.D.M., Unni K.K., Mertens F., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Geneva: IARC Press; 2002. Pp. 227-232.Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи 2012;4:3-10.Aliev M.D., Sushentsov E.A. Oncoorthopedics today. Sarkomy kostey, myagkikh tkaney i opukholi kozhi = Sarcomas of bones, soft tissues and skin tumors 2012;4:3-10. (In Russ.).Ewing J. The classic: diffuse endothelioma of bone. Proceedings of the New York Pathological Society. 1921;12:17. Clin Orthop Relat Res 2006;450:25-7. doi: 10.1097/01.blo.0000229311.36007.c7.Ewing J. The classic: diffuse endothelioma of bone. Proceedings of the New York Pathological Society. 1921;12:17. Clin Orthop Relat Res 2006;450:25-7. doi: 10.1097/01.blo.0000229311.36007.c7.Эпидемиология злокачественных новообразований у детей: основные показатели в 2011-2016 гг. Под ред. М.Ю. Рыкова, В.Г. Полякова. М.: Первый МГМУ им. И.М. Сеченова, 2017. 208 с.Epidemiology of malignant tumors in children: the main indicators in 2011-2016. Eds. M.Yu. Rykov, V.G. Polyakov. M.: Pervyi MGMU im. I.M. Sechenova, 2017. 208 p. (In Russ.).Fletcher C.D., Bridge J.A., Hogendoorn P.C., Mertens F., eds. Pathology and genetics of tumours of soft tissue and bone. Vol. 5. 4th ed. WHO, 2013.Fletcher C.D., Bridge J.A., Hogendoorn P.C., Mertens F., eds. Pathology and genetics of tumours of soft tissue and bone. Vol. 5. 4th ed. WHO, 2013.Nomikos G.C., Murphey M.D. Primary Bone tumors of lower extremities. Radiol Clin North Am 2002;40(5):971-90. doi: 10.1016/s0033-8389(02)00038-6.Nomikos G.C., Murphey M.D. Primary Bone tumors of lower extremities. Radiol Clin North Am 2002;40(5):971-90. doi: 10.1016/s0033-8389(02)00038-6.Hapani H., Kalola J., Hapani J. Comparative role of CT scan and MR imaging in primary malginant bone tumors. IOSR J Dent Med Sci 2014;13(11):29-35. doi: 10.9790/0853-131173643.Hapani H., Kalola J., Hapani J. Comparative role of CT scan and MR imaging in primary malginant bone tumors. IOSR J Dent Med Sci 2014;13(11):29-35. doi: 10.9790/0853-131173643.Putta T., Gibikote S., Madhuri V., Walter N. Accuracy of Various MRI Sequences in Determining the Tumour Margin in Musculoskeletal Tumours. Pol J Radiol 2016;81:540-8. doi: 10.12659/PJR.898108.Putta T., Gibikote S., Madhuri V., Walter N. Accuracy of Various MRI Sequences in Determining the Tumour Margin in Musculoskeletal Tumours. Pol J Radiol 2016;81:540-8. doi: 10.12659/PJR.898108.Verstraete K.L., Lang P. Bone and Soft Tissue Tumors: The Role of Contrast Agents for MR Imaging. Eur J Radiol 2000;34(3):229-46. doi: 10.1016/s0720-048x(00)00202-3.Verstraete K.L., Lang P. Bone and Soft Tissue Tumors: The Role of Contrast Agents for MR Imaging. Eur J Radiol 2000;34(3):229-46. doi: 10.1016/s0720-048x(00)00202-3.Verstraete K.L., Van der Woude H.J., Hogendoorn P.C., De Deene Y., Kunnen M., Bloem J.L. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 1996;6(2):311-21. doi: 10.1002/jmri.1880060210.Verstraete K.L., Van der Woude H.J., Hogendoorn P.C., De Deene Y., Kunnen M., Bloem J.L. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 1996;6(2):311-21. doi: 10.1002/jmri.1880060210.Shapeero L.G., Vanel D., Verstraete K.L., Bloem J.L. Dynamic contrast-enhanced MR imaging for soft tissue sarcomas. Semin Musculoskeletal Radiol 1999;3(2):101-13. doi: 10.1055/s-2008-1080055.Shapeero L.G., Vanel D., Verstraete K.L., Bloem J.L. Dynamic contrast-enhanced MR imaging for soft tissue sarcomas. Semin Musculoskeletal Radiol 1999;3(2):101-13. doi: 10.1055/s-2008-1080055.Shah L.M., Hanrahan C.J. MRI of spinal bone marrow: part I, techniques and normal age-related appearances. Am J Roentgenol 2011;197(6):1298-308. doi: 10.2214/AJR.11.7005.Shah L.M., Hanrahan C.J. MRI of spinal bone marrow: part I, techniques and normal age-related appearances. Am J Roentgenol 2011;197(6):1298-308. doi: 10.2214/AJR.11.7005.Disler D.G., McCauley T.R., Ratner L.M., Kesack C.D., Cooper J.A. In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. Am J Roentgenol 1997;169(5):1439-47. doi: 10.2214/ajr.169.5.9353477.Disler D.G., McCauley T.R., Ratner L.M., Kesack C.D., Cooper J.A. In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. Am J Roentgenol 1997;169(5):1439-47. doi: 10.2214/ajr.169.5.9353477.Епифанова С.В., Седых С.А., Тепляков В.В., Карпенко В.Ю., Бухаров А.В., Державин В.В., Шаталов А.М., Мыслевцев И.В. Магнитно-резонансная и компьютерная томография в оценке местной распространенности первичных опухолей костей конечностей. Вестник Российского научного центра рентгенорадиологии Минздрава России 2011;11.Epifanova S.V., Sedykh S.A., Teplyakov V.V., Karpenko V.Yu., Bukharov A.V., Derzhavin V.A., Shatalov A.M., Myslevtsev I.V. The role of MRI and CT at estimation local advance of primary tumor of bone extremity. Vestnik Rossiyskogo nauchnogo tsentra rentgenoradiologii Minzdrava Rossii = Bulletin of the Russian Scientific Center for Roentgenoradiology of the Ministry of Health of Russia 2011;11. (In Russ.).Fayad L.M., Bluemke D.A., McCarthy E.F., Weber K.L., Barker P.B., Jacobs M.A. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 2006;23(1):23-8. doi: 10.1002/jmri.20448.Fayad L.M., Bluemke D.A., McCarthy E.F., Weber K.L., Barker P.B., Jacobs M.A. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 2006;23(1):23-8. doi: 10.1002/jmri.20448.Fayad L.M., Salibi N., Wang X., Machado A.J., Jacobs M.A., Bluemke D.A., Barker P.B. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. Am J Roentgenol 2010;194(1):73-9. doi: 10.2214/AJR.09.3125.Fayad L.M., Salibi N., Wang X., Machado A.J., Jacobs M.A., Bluemke D.A., Barker P.B. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. Am J Roentgenol 2010;194(1):73-9. doi: 10.2214/AJR.09.3125.Wang C.K., Li C.W., Hsieh T.J., Chien S.H., Liu G.C., Tsai K.B. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology 2004;232(2):599-605. doi: 10.1148/radiol.2322031441.Wang C.K., Li C.W., Hsieh T.J., Chien S.H., Liu G.C., Tsai K.B. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology 2004;232(2):599-605. doi: 10.1148/radiol.2322031441.Subhawong T.K., Wang X., Durand D.J., Jacobs M.A., Carrino J.A., Machado A.J., Fayad L.M. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. Am J Roentgenol 2012;198(1):162-72. doi: 10.2214/AJR.11.6505.Subhawong T.K., Wang X., Durand D.J., Jacobs M.A., Carrino J.A., Machado A.J., Fayad L.M. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. Am J Roentgenol 2012;198(1):162-72. doi: 10.2214/AJR.11.6505.Hsieh T.J., Li C.W., Chuang H.Y., Liu G.C., Wang C.K. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. J Comput Assist Tomogr 2008;32(6):987-94. doi: 10.1097/RCT.0b013e31815b9ce9Hsieh T.J., Li C.W., Chuang H.Y., Liu G.C., Wang C.K. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. J Comput Assist Tomogr 2008;32(6):987-94. doi: 10.1097/RCT.0b013e31815b9ce9Golfieri R., Baddeley H., Pringle J.S., Leung A.W., Greco A., Souhami R. MRI in primary bone tumors: therapeutic implications. Eur J Radiol 1991;12:201-7. doi: 10.1016/0720-048x(91)90073-5.Golfieri R., Baddeley H., Pringle J.S., Leung A.W., Greco A., Souhami R. MRI in primary bone tumors: therapeutic implications. Eur J Radiol 1991;12:201-7. doi: 10.1016/0720-048x(91)90073-5.

The authors declare that there are no conflicts of interest present.